These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 27400689)
1. Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study. Midani D; Parkman HP J Neurogastroenterol Motil; 2016 Oct; 22(4):650-655. PubMed ID: 27400689 [TBL] [Abstract][Full Text] [Related]
2. Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis. Simmons K; Parkman HP Dig Dis Sci; 2014 Jun; 59(6):1231-4. PubMed ID: 24615549 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary. Heckert J; Parkman HP Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425 [TBL] [Abstract][Full Text] [Related]
4. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754 [TBL] [Abstract][Full Text] [Related]
5. Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort. Schey R; Saadi M; Midani D; Roberts AC; Parupalli R; Parkman HP Dig Dis Sci; 2016 Dec; 61(12):3545-3551. PubMed ID: 27530760 [TBL] [Abstract][Full Text] [Related]
6. Gastric Electric Stimulation for Refractory Gastroparesis: A Prospective Analysis of 151 Patients at a Single Center. Heckert J; Sankineni A; Hughes WB; Harbison S; Parkman H Dig Dis Sci; 2016 Jan; 61(1):168-75. PubMed ID: 26280084 [TBL] [Abstract][Full Text] [Related]
7. Meal Eating Characteristics of Patients with Gastroparesis. Hagopian GG; Johnson KP; Shahsavari D; Parkman HP Dig Dis Sci; 2022 Aug; 67(8):3872-3880. PubMed ID: 34324088 [TBL] [Abstract][Full Text] [Related]
8. Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis. Li JL; Li M; Pang B; Zhou Q; Tian JX; Liu HX; Zhao XY; Tong XL World J Gastroenterol; 2014 Jul; 20(26):8674-80. PubMed ID: 25024625 [TBL] [Abstract][Full Text] [Related]
9. Mirtazapine for symptom control in refractory gastroparesis. Malamood M; Roberts A; Kataria R; Parkman HP; Schey R Drug Des Devel Ther; 2017; 11():1035-1041. PubMed ID: 28408802 [TBL] [Abstract][Full Text] [Related]
10. Surgical Treatment for Refractory Gastroparesis: Stimulator, Pyloric Surgery, or Both? Zoll B; Jehangir A; Edwards MA; Petrov R; Hughes W; Malik Z; Parkman HP J Gastrointest Surg; 2020 Oct; 24(10):2204-2211. PubMed ID: 31512100 [TBL] [Abstract][Full Text] [Related]
11. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying, and gastroparesis severity. Parkman HP; Yates K; Hasler WL; Nguyen L; Pasricha PJ; Snape WJ; Farrugia G; Koch KL; Abell TL; McCallum RW; Lee L; Unalp-Arida A; Tonascia J; Hamilton F; Gastroenterology; 2011 Jan; 140(1):101-15. PubMed ID: 20965184 [TBL] [Abstract][Full Text] [Related]
12. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Cassilly DW; Wang YR; Friedenberg FK; Nelson DB; Maurer AH; Parkman HP Digestion; 2008; 78(2-3):144-51. PubMed ID: 19033686 [TBL] [Abstract][Full Text] [Related]
13. Gastric electrical stimulation: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486 [TBL] [Abstract][Full Text] [Related]
14. Pyloric sphincter characteristics using EndoFLIP Saadi M; Yu D; Malik Z; Parkman HP; Schey R Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):375-384. PubMed ID: 29709494 [TBL] [Abstract][Full Text] [Related]
15. Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing. Parkman HP; Hallinan EK; Hasler WL; Farrugia G; Koch KL; Nguyen L; Snape WJ; Abell TL; McCallum RW; Sarosiek I; Pasricha PJ; Clarke J; Miriel L; Tonascia J; Hamilton F; Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27781342 [TBL] [Abstract][Full Text] [Related]
16. Symptom variability throughout the day in patients with gastroparesis. Shahsavari D; Yu D; Jehangir A; Lu X; Zoll B; Parkman HP Neurogastroenterol Motil; 2020 Feb; 32(2):e13740. PubMed ID: 31782211 [TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis. Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235 [TBL] [Abstract][Full Text] [Related]
18. Hair Loss in Patients with Gastroparesis: A Sign of Nutritional Deficiency in Gastroparesis? Silver PJ; Coles MJ; Heath CR; Parkman HP Dig Dis Sci; 2023 Apr; 68(4):1397-1402. PubMed ID: 36853546 [TBL] [Abstract][Full Text] [Related]
19. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis. Maranki JL; Lytes V; Meilahn JE; Harbison S; Friedenberg FK; Fisher RS; Parkman HP Dig Dis Sci; 2008 Aug; 53(8):2072-8. PubMed ID: 18080765 [TBL] [Abstract][Full Text] [Related]
20. Relationships among intragastric meal distribution during gastric emptying scintigraphy, water consumption during water load satiety testing, and symptoms of gastroparesis. Parkman HP; Wilson LA; Silver P; Maurer AH; Sarosiek I; Bulat RS; Kuo B; Grover M; Farrugia G; Chumpitazi BP; Shulman RJ; Malik Z; Miriel LA; Tonascia J; Hamilton F; Abell TL; Pasricha PJ; McCallum RW; Koch KL; Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G407-G417. PubMed ID: 37552206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]